Xbiome
Xbiome, founded in 2017, is a leading AI microbiome research and industrial transformation platform in China. The company aims to alleviate or treat diseases through microbiological and bioinformatics technologies, utilizing live biopharmaceuticals and microbial small molecule regulators. Their products, including fecal microbiota transplantation (FMT) and probiotics, are designed to benefit public health. Xbiome has built a world-class bioinformatics analysis and transformation platform, significantly enhancing drug development efficiency and success rates, and is positioned at the forefront of the microbiome pharmaceutical industry.
Xbiome
Xbiome, founded in 2017, is a leading AI microbiome research and industrial transformation platform in China. The company aims to alleviate or treat diseases through microbiological and bioinformatics technologies, utilizing live biopharmaceuticals and microbial small molecule regulators. Their products, including fecal microbiota transplantation (FMT) and probiotics, are designed to benefit public health. Xbiome has built a world-class bioinformatics analysis and transformation platform, significantly enhancing drug development efficiency and success rates, and is positioned at the forefront of the microbiome pharmaceutical industry.